StockData
X4 Pharmaceuticals, Inc logo

X4 Pharmaceuticals, Inc (XFOR) stock

XFORNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 3/30
$3.09+0.26 (+9.19%)

Close on Nov 17, 2026Market cap $306.36MP/E –Yield –

X4 Pharmaceuticals market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

X4 Pharmaceuticals's market cap was $310.45M on Nov 11, 2026, against $91.53M a year earlier. Over the last 5 years it ranged from $9.73M to $440.47M, with a median of $112.58M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$310.45M+208.6%
2025Dec 31, 2025$100.59M-18.6%
2024Dec 31, 2024$123.63M-10.3%
2023Dec 29, 2023$137.88M+102.0%
2022Dec 30, 2022$68.26M+20.6%
2021Dec 31, 2021$56.59M-46.0%
2020Dec 31, 2020$104.73M-21.3%
2019Dec 31, 2019$133.08M+1970.1%
2018Dec 31, 2018$6.43M+407.0%
2017Dec 29, 2017$1.27M–

More X4 Pharmaceuticals figures

See a number that looks wrong?